A vial with the Johnson & Johnson’s one-dose COVID-19 vaccine is seen at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. THE CANADIAN PRESS/AP/Mary Altaffer

A vial with the Johnson & Johnson’s one-dose COVID-19 vaccine is seen at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. THE CANADIAN PRESS/AP/Mary Altaffer

What we know about J&J’s single-dose vaccine, set to arrive at the end of April

Canada approved the vaccine in early March and had pre-ordered 10 million doses

Canada will soon add another COVID-19 vaccine to its supply, with procurement minister Anita Anand announcing this week that initial shipments of Johnson & Johnson’s single-dose jab are to arrive by the end of April.

Canada approved the vaccine in early March and had pre-ordered 10 million doses, but manufacturing problems from the company led to shipment delays to Canada and elsewhere.

Anand did not have details when she made her announcement Tuesday about how many doses would be included in the first shipment.

Johnson & Johnson gives Canada four distinct vaccines — along with Pfizer-BioNTech, Moderna and Oxford-AstraZeneca — and its one-and-done element adds flexibility to the country’s plan to immunize the majority of its residents by September.

Dr. Sumon Chakrabarti, an infectious disease expert in Mississauga, Ont., says that while the vaccines are arriving later than expected, they’ll be a welcome addition to Canada’s rollout.

“A single-dose vaccine, as well as the fact it only requires a regular fridge (to store it), that is so huge in terms of taking this vaccine and bringing it to targeted populations,” he said. “I wish it was (arriving before) the end of April, but I’ll take it.”

Johnson & Johnson hit another manufacturing bump Wednesday, announcing that a batch of its vaccine had failed quality standards and can’t be used.

The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries.

Here’s what we know about Johnson & Johnson’s vaccine:

HOW EFFECTIVE IS IT?

Johnson & Johnson announced promising results from its Phase 3 clinical trials at the end of January, suggesting its vaccine reduced severe COVID-19 disease by 85 per cent, and prevented 100 per cent of COVID-related hospitalization or death.

The vaccine had a 72 per cent efficacy in preventing COVID infections after 28 days in the company’s U.S. trials. The efficacy dropped to 66 per cent when averaging in results from other global trials, including a South African study that factored in more transmissible variants of the COVID virus.

Pfizer and Moderna showed 95 per cent efficacy in their respective trials, but those were tested against previous dominant strains and didn’t account for variants that have popped up since.

Pfizer, Moderna and AstraZeneca also had zero hospitalizations and deaths in their trials.

Chakrabarti says it’s important to distinguish the timing of the four trials, and stressed that they all work exceedingly well the metrics that matter most.

“All four of these vaccines … are exceptionally effective at preventing hospitalization and death,” he said. “Those are the two things that we care about.”

WHAT ARE THE BENEFITS OF THIS VACCINE?

The ease of distribution offered by a single-dose shot — unlike the two-dose vaccines from Pfizer, Moderna and AstraZeneca — and its ability to be stored in a regular fridge are among Johnson & Johnson’s biggest strengths.

Pfizer’s vaccine initially required ultra-cold storage temperatures between -60 C and -80 C, though Health Canada recently said it could be stored in a regular freezer for up to 14 days. Moderna’s vaccine can also be stored at regular freezer temperatures while AstraZeneca can be stored in a fridge.

Chakrabarti says Johnson & Johnson’s product is conducive to large, mobile vaccine clinics that can be set up quickly to target populations in hard-hit communities, especially essential workers.

“You can transport the vaccine there and just boom, boom, boom, get it into people’s arms,” he said. “The timing doesn’t help — we really wanted to start (vaccinating) essential workers as quickly as possible … But it’s something you can do (easily) with J&J.”

Chakrabarti added that Johnson & Johnson may also benefit from not having the string of confusing messaging surrounding it that AstraZeneca has had.

Canada’s National Advisory Committee on Immunization (NACI) has set age recommendations on AstraZeneca three times. The latest recommendation is to pause the use of AstraZeneca in those under 55 due to rare blood clot links that were observed in Europe.

READ MORE: Trudeau says Johnson & Johnson vaccine faces production challenges

Omar Khan, an assistant professor in biomedical engineering at the University of Toronto, says Johnson & Johnson could slot into the void left by provinces not using AstraZeneca on those under 55.

“That (decision by NACI) effectively reduced our vaccine supply,” Khan said. “But with this we can make up that loss of supply for that population and hopefully get us back on track.”

The fact that Johnson & Johnson is already in use in the U.S. may give Canadians more confidence in it, Chakrabarti says.

The FDA authorized Johnson & Johnson on Feb. 27 for emergency use — just as it had for Pfizer and Moderna in December — but shipments to the U.S. were also affected by manufacturing problems early on. The bulk of vaccine use in the U.S. has been Pfizer and Moderna.

“It’s very good when you see other countries having experience with it,” he said, adding that a mountain of positive AstraZeneca data also exists from the U.K., as well as data from Israel on the high effectiveness of Pfizer.

WHAT KIND OF VACCINE TECHNOLOGY IS USED?

Unlike the mRNA used in Pfizer and Moderna’s products, Johnson & Johnson is a non-replicating viral vector vaccine similar to AstraZeneca’s.

That means it uses a different harmless virus, which can’t copy itself, as a vector to give our cells the instructions they need to make the coronavirus’s spike protein.

The immune system recognizes the protein and makes antibodies, which then allow us to fend off attack if exposed in the future.

Khan says it takes a couple weeks for the body to build up immunity with any of the vaccines, but those receiving Johnson & Johnson should especially take note of that.

“Yes, it’s one dose so people might say ‘one and done, ready to go,’ but you still need to give yourself the bare minimum two weeks,” he said. “Ideally, give yourself a month, and then you’ll have a higher level of protection.”

Melissa Couto Zuber, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

The old Yount school in Youbou has stood empty for years, but now a group has plans to turn it into a mixed-use property with affordable housing and tourist services. (Submitted)
Group sets sights on tranforming old Yount school property in Youbou

School District 79 has already commenced a process to sell the school through a formal proposal call

North Cowicha to extend the time lines of its official community plan update. (File photo)
North Cowichan to extend time line of OCP review

Municipality also adds $55,000 to OCP budget

Cowichan Capitals’ Logan Rands digs for the puck along the boards in the Alberni Valley Bulldogs’ zone midway through the third period of their BC Hockey League game at the Alberni Valley Multiplex on Saturday, April 10, 2021. (SUSAN QUINN/ Alberni Valley News)
Cowichan Capitals pick up first two wins of BCHL season

Brockman, Moffatt both up to four goals on the year

A nearly four-hour standoff at an apartment complex on Cowichan Lake Road in Duncan ended peacefully on Wednesday, April 14. (Kevin Rothbauer/Citizen)
Standoff at Duncan apartment ends peacefully

Police surround building as homeowner held in apartment by adult son

B.C. Centre for Disease Control maps showing new COVID-19 cases by local health area for the week of April 4-10. (BCCDC image)
Parksville-Qualicum passes Nanaimo in new COVID-19 cases

Greater Victoria had more new cases than any other Island area: B.C. Centre for Disease Control

A woman wears a protective face covering to help prevent the spread of COVID-19 as she walks past the emergency entrance of Vancouver General Hospital in Vancouver, B.C., Friday, April 9, 2021. COVID-19 cases have been on a steady increase in the province of British Columbia over the past week. THE CANADIAN PRESS/Jonathan Hayward
Top doctor warns B.C.’s daily cases could reach 3,000 as COVID hospitalizations surge

There are more than 400 people in hospital, with 125 of them in ICU

The family of Iris McNeil, shown here with members of her family, has launched a petition to deny parole for the man who murdered McNeil in 1997. (Family photo)
Family fights killer’s release from Vancouver Island prison

Shortreed serving an indeterminate sentence at William Head Institution

B.C. Premier John Horgan wears a protective face mask to help prevent the spread of COVID-19. THE CANADIAN PRESS/Jonathan Hayward
B.C. Premier John Horgan booked to get AstraZeneca shot Friday

‘Let’s show all British Columbians that the best vaccine is the one that’s available to you now,’ he said

Doses of the Moderna COVID‑19 vaccine in a freezer trailer, to be transported to Canada during the COVID-19 pandemic. THE CANADIAN PRESS/Nathan Denette
Canada’s incoming supply of Moderna vaccine slashed in half through end of April

Moderna plans to ship 650,000 doses of its vaccine to Canada by the end of the month, instead of the expected 1.2 million

Dr. Bonnie Henry speaks about the province’s COVID-19 vaccine plans during a news conference at the legislature in Victoria. THE CANADIAN PRESS/Chad Hipolito
P.1 variant likely highest in B.C. due to more testing for it: Dr. Henry

Overall, just under 60% of new daily cases in the province involve variants

The father of Aaliyah Rosa planted a tree and laid a plaque in her memory in 2018. (Langley Advance Times files)
Final witness will extend Langley child murder trial into May or June

Lengthy trial began last autumn with COVID and other factors forcing it to take longer than expected

A crossing guard stops traffic as students wearing face masks to curb the spread of COVID-19 arrive at Ecole Woodward Hill Elementary School, in Surrey, B.C., on Tuesday, February 23, 2021. A number of schools in the Fraser Health region, including Woodward Hill, have reported cases of the B.1.7.7 COVID-19 variant first detected in the U.K. THE CANADIAN PRESS/Darryl Dyck
COVID-infected students in Lower Mainland schools transmitting to 1 to 2 others: data

Eight to 13 per cent of COVID cases among students in the Lower Mainland were acquired in schools, B.C. says

Norm Scott, president of Royal Canadian Legion Branch # 91, is disappointed the Legion does not qualify for COVID financial assistance from the provincial government. (Black Press Media file photo)
B.C.’s pandemic aid package passing Legion branches by

Federal non-profit status stymies provincial assistance eligibility

Latest modelling by public health shows cases generated by COVID-19 infections into places where it can spread quickly. (B.C. Centre for Disease Control)
Industrial sites, pubs, restaurants driving COVID-19 spread in B.C.

Infection risk higher in offices, retail, warehouses, farms

Most Read